[Usefulness of cardiac troponin I in patients with acute myocardial infarction]
- PMID: 12451679
[Usefulness of cardiac troponin I in patients with acute myocardial infarction]
Abstract
Cardiac troponin(cTn) is a sensitive marker for acute myocardial infarction(AMI). However, some cases of renal failure have been reported to show false positive results for cardiac troponin T(cTnT). Recently, it has been reported that heart-type fatty acid-binding protein(H-FABP) is a sensitive marker for AMI in the early phase. We evaluated the usefulness of cardiac troponin I(cTNI) using serum samples from patients(age 57-96) confirmed to have AMI with chest pain(n = 48), unstable angina pectoris(n = 11), cardiac failure(n = 5), others with high creatine phosphokinase(CK) activity(n = 81) and renal failure(n = 28), by comparing among cTnT(qualitative and quantitative), H-FABP, CK and creatine phosphokinase isoenzyme MB(CK-MB) activity. The diagnostic validity of cTn was assessed by receiver operating characteristic(ROC) curve analysis. The cut off value for AMI of cTnI was 0.8 ng/ml, cTnT was 0.16 ng/ml and H-FABP was 19.0 ng/ml. The overall diagnostic sensitivity of cTnI was 83.1%, and 84.8% for cTnT (quantitative), 72.3% for cTnT(qualitative), 64.8% for H-FABP, 81.8% for CK and 59.3% for CK-MB. The overall diagnostic specificity of cTnI was 90.9%, and 81.3% for cTnT(quantitative), 60.5% for cTnT (qualitative), 53.2% for H-FABP, 52.9% for CK and 87.7% for CK-MB. The overall diagnostic efficiency of cTnI was 86.5%, and 82.7% for cTnT(quantitative), 63.6% for cTnT(qualitative), 59.8% for H-FABP, 69.0% for CK and 71.9% for CK-MB. False positive results for cTnI were found in a few cases with renal failure. cTnT(qualitative) showed false positive results in 22/28 with serum creatinine over 2.1 mg/dl due to renal failure. In conclusion, cTnI detection is considered a useful and sufficiently sensitive marker for AMI.
Similar articles
-
Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB.Clin Chem Lab Med. 2000 Mar;38(3):231-8. doi: 10.1515/CCLM.2000.034. Clin Chem Lab Med. 2000. PMID: 10905760
-
Role of heart-type fatty acid binding protein in early detection of acute myocardial infarction in comparison with cTnI, CK-MB and myoglobin.J Huazhong Univ Sci Technolog Med Sci. 2004;24(5):449-51, 459. doi: 10.1007/BF02831105. J Huazhong Univ Sci Technolog Med Sci. 2004. PMID: 15641689
-
Laboratory diagnosis of patients with acute chest pain.Clin Chem Lab Med. 2000 Mar;38(3):187-97. doi: 10.1515/CCLM.2000.027. Clin Chem Lab Med. 2000. PMID: 10905753 Review.
-
Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain.Indian Heart J. 2015 Nov-Dec;67(6):538-42. doi: 10.1016/j.ihj.2015.06.035. Epub 2015 Oct 26. Indian Heart J. 2015. PMID: 26702681 Free PMC article.
-
Cardiac markers in the assessment of acute coronary syndromes.Md Med J. 1997;Suppl:18-24. Md Med J. 1997. PMID: 9470339 Review.
Cited by
-
Biochemical markers of myocardial injury.Indian J Clin Biochem. 2007 Mar;22(1):10-7. doi: 10.1007/BF02912874. Indian J Clin Biochem. 2007. PMID: 23105645 Free PMC article.
-
Diagnostic Value of Echocardiography Combined with Serum h-FABP and cTnI in Myocardial Infarction and Its Evaluation Value in Left Ventricular Function.Evid Based Complement Alternat Med. 2022 May 24;2022:8809708. doi: 10.1155/2022/8809708. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Jun 21;2023:9850326. doi: 10.1155/2023/9850326. PMID: 35656464 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous